Recent RXRX Stock Price | RXRX Stock Predictions | |
$8.12 | +60.10% |
$13.00 |
Recent RXRX Analyst Ratings Breakdown, Making RXRX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 5 | 5 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.57 | 2.57 | 2.57 | 2.57 |
For the RXRX stock predictions from the analysts covering Recursion Pharmaceuticals Inc, we have collected all of the individual RXRX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering RXRX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since RXRX stock predictions may vary widely, another useful metric to consider is the median RXRX stock prediction, which represents the price at which half of the analysts
made RXRX stock predictions that were higher and half made RXRX stock predictions that were lower. This makes for a different take on the RXRX stock predictions out there, as compared to average or mean.
And that median across all the individual RXRX stock predictions was: $12.5 as of 2024-04-29.
The very highest of the RXRX stock predictions for one year price target was $17.0, while the very lowest of the RXRX stock predictions in the analyst group was
$10.0 (with a standard deviation of $3.098). Get the latest Zacks research report on RXRX — FREE
Find out: RXRX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
NREF Stock Predictions
SLGN Stock Predictions
HBIO Stock Predictions
WLK Stock Predictions
WAFD Stock Predictions
SLCT Stock Predictions
TREX Stock Predictions
APLS Stock Predictions
INTC Stock Predictions
|
|
Hold (2.43 out of 4) 10th percentile
(ranked lower than approx. 90% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |